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Abstract
Objective: Patients with non-ischaemic systolic heart failure (HF) and idiopathic dilated 
cardiomyopathy (DCM) are a heterogenous group with varied morbidity and mortality. 
Prognostication in this group is challenging. We performed a systematic review and  
meta-analysis to examine the significance of the presence of contractile reserve as assessed 
via stress imaging on mortality and hospitalisation.
Methods: A search for studies that non-invasively assessed contractile reserve in patients 
with DCM or non-ischaemic HF with reduced ejection fraction, stress imaging with 
follow-up data comparing outcomes. A range of imaging modalities and stressors were 
included. We examined primary endpoints of mortality and secondary endpoints of 
combined cardiovascular events including HF progression or hospitalisation. Our analysis 
compared endpoints in patients with contractile reserve and those without it.
Results: Nine prospective cohort studies were identified describing a total of 787 patients. 
These studies are methodologically but not statistically heterogenous (I2 = 31%). Using a 
random effect model, the presence of contractile reserve was associated with a significantly 
lower risk of mortality and cardiovascular events odds ratios of 0.20 (CI 0.11, 0.39) 
(P < 0.00001) and 0.13 (CI 0.04, 0.40) (P = 0.0004), respectively.
Conclusion: Regardless of stressor and imaging modality and despite the significant 
methodological heterogeneity within the current data (imaging techniques and 
parameters), patients with non-ischaemic cardiomyopathy and reduced EF who 
demonstrate contractile reserve have a lower mortality, and lower events/hospitalisations. 
The presence of contractile reserve therefore offers a potential positive prognostic 
indicator when managing these patients.
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Introduction
Systolic heart failure (HF) is a heterogenous disease 
with a varied prognosis which can be poor despite best 
modern medical therapy (1). An accurate assessment of 
prognosis allows patients to receive better counselling 
before embarking on complex therapies including devices 
and referral for transplantation as well as providing 
appropriate end-of-life care with an appropriate timescale.
The ability to identify high-risk patients at initial 
assessment allows appropriately targeted specialist care 
and more intensive follow-up for those at high risk of 
admission and disease progression.
The current European Society of Cardiology 
guidelines do not provide a consensus on the best 
approach to prognostication in this patient group; 
however, they acknowledge that there should be a 
multimodality approach (2). Although several prognostic 
HF models exist and may help predict cardiac mortality 
in patients with HF, they are less useful for prediction of 
hospitalisations and a recent meta-analysis and meta-
regression study of 117 prognostic models revealed only 
a moderate accuracy of models predicting mortality (3). 
Stress echocardiography plays a role in the assessment 
of a range of cardiac disease as evidenced by current 
European guidelines (4) but its place in the non-ischaemic 
systolic HF group is less clear and is not currently used 
regularly in clinical practice. Whilst useful in defining 
the presence of systolic HF, echocardiography-defined 
bands of severity (mild/moderate/severe) provide little 
incremental prognostic discrimination. NYHA class and 
EF severity (5, 6, 7) are associated with adverse outcomes 
but have significant limitations with respect to their long-
term prognostic power (8).
The use of stress echocardiography to assess contractile 
reserve has shown promise as a prognostic indicator in 
the assessment of systolic HF (9) and specifically in the 
idiopathic dilated cardiomyopathy (DCM) subgroup (10). 
Current data describing the assessment of contractile 
reserve are highly varied and the generalisability of studies 
is limited by small cohort numbers and differing indices 
of contractile reserve.
‘Contractile reserve’ refers to the difference between 
myocardial contractility at rest compared to stress 
either through physiological means with exercise or 
pharmacological means such as the beta-adrenergic 
effects of dobutamine. Dipyridamole is predominantly 
vasodilatory causing increased coronary flow through 
inhibition of cellular re-uptake of adenosine. This 
increase in coronary perfusion may promote a rise in 
cardiac contractility through the Gregg phenomenon 
(11). Additionally, adenosine accumulation may exert 
direct sympathomimetic chemoreceptor activity 
stimulating cardiac contractility (12). The assessment of 
contractile reserve gives an indication of cardiac reserve 
i.e. the maximum amount by which cardiac output 
can be increased from a state of rest. Dobutamine stress 
assessment of contractile reserve may give an indication 
of beta-adrenergic receptor sensitivity and/or density in 
the myocardium of patients with DCM with mild or no 
symptoms (13).
Assessment of the presence of contractile reserve with 
non-invasive imaging techniques relies upon reliable 
and reproducible methods with clear parameters. These 
indices include an assessment of change in systolic 
function or LV dimensions with stress. Commonly used 
echocardiographic parameters include assessment of 
change in LV ejection fraction, wall motion score index 
(WMSI), LV dimensions and more recently LV global strain 
in the form of global circumferential and longitudinal 
strain % change. Radionuclide methods tend to use 
change in ejection fraction.
The objective of this systematic review and meta-
analysis was to describe the current literature and to 
determine, with a higher degree of precision, whether 
reduced or absent contractile reserve in patients with 
non-ischaemic systolic HF predicts future events.
Methods
Search strategy
A literature search was performed using PubMed, Embase, 
Ovid, Google Scholar and the Cochrane Library for studies 
published between 1990 and 2016 in all languages. The 
PRISMA guidelines were adhered to for our meta-analysis. 
Authors of studies that were not published in English 
were contacted by email to request English versions. 
Authors of studies were also contacted by email to request 
clarification of data as required. Review articles relevant 
to this subject and their reference lists were also reviewed. 
Where the study subject was relevant but published data 
were inadequate for this meta-analysis, authors were 
emailed for clarification of unpublished data; we received 
1 response with no additional data provided.
The following search criteria were used: ‘systolic HF 
and contractile reserve prognosis’; ‘DCM and contractile 
reserve’. Figure 1 illustrates our search strategy following 
the PRISMA guidelines (14).
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Inclusion and exclusion criteria
Articles were included in this meta-analysis if they 
involved any of the following:
1. Studies investigating the presence of contractile reserve 
in patients with non-ischaemic systolic HF and/or 
idiopathic DCM.
2. Imaging modalities included were transthoracic 
echocardiography with stress agents including 
dobutamine, exercise, dipyridamole or adenosine and 
radionuclide angiography.
3. Studies showing prognostic data with mortality or 
combined endpoints of cardiovascular events.
4. The following exclusion criteria were used: studies 
<20 patients, follow-up period of <12  months 
and prognostic data without clear comparison of 
contractile reserve. Studies were compared to ensure 
that the populations had not overlapped.
The studies were unmatched in terms of population 
demographics and represented the heterogenous patient 
population with non-ischaemic systolic HF. The clinical 
definitions for patients with DCM and exclusion methods 
for ischaemic heart disease were compared, and these 
often referred to now outdated WHO definitions from 
1995 (15). The imaging modalities, indices recorded and 
methodology of stress were also compared in addition to 
baseline patient characteristics.
Outcomes
The primary outcome was total mortality. Secondary 
outcomes were combined cardiovascular and cardiac 
events including hospitalisation from decompensated 
HF and cardiac transplantation. The following variables 
were also assessed: methodology of contractile reserve 
assessment and criteria for presence of contractile reserve.
Statistical analysis
For each study, odds ratios (ORs) and confidence intervals 
(CIs) were calculated, both for primary and secondary 
outcomes. Because of methodological heterogeneity in 
Figure 1
Search strategy following the PRISMA guidelines 
(14).
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the included studies, a random effect model was used 
to calculate the summary statistics and their 95% CIs. 
Statistical heterogeneity was assessed using with the chi-
squared test. Data analysis was performed using Review 
Manager Version 5.3 (The Cochrane Collaboration, Update 
Software, Oxford, United Kingdom). Statistical support 
was provided by Paul Bassett, Statistical Consultant.
Results
Initial search results yielded 900, and following exclusion 
of duplicates, there were 185 potential studies for analysis; 
of these, 153 studies or review articles were excluded from 
their title as they did not assess the relevant patient group 
or clinical question. One relevant study had no available 
English translation, 2 included patients with mixed HF 
including ischaemic heart disease, 2 had no prognostic 
data and 1 paper had a follow-up period of <6 months. 
Twenty-five full-text articles were then requested and 
screened. Of these, 16 were then excluded due to lack of 
clarity regarding their prognostic data or comparison of 
patients with and without contractile reserve.
The total number of patients included in the 
remaining 9 studies was 787. Of these, 7 studies addressed 
the primary outcome of mortality, involving 580 patients. 
Pinamonti 2004 and Ramahi 2001 assessed transplant-
free survival as the primary outcome; all others used 
cardiac or all-cause mortality as their primary outcome. 
Assessment of secondary outcomes of HF progression or 
hospitalisation was performed in 2 studies (11, 27) with 
175 patients; these have been included in a separate 
analysis. These studies did not have significant statistical 
heterogeneity (I2 = 31%).
Assessment of contractile reserve in response to 
stressors (dobutamine/exercise/dipyridamole) was 
assessed most commonly using change in WMSI, used 
in 6 studies. The change in WMSI considered significant 
for the presence of contractile reserve varied from 0.15 to 
0.44, with ≥0.25 being used in 3 studies. The 3 studies not 
using WMSI all assessed change in LV EF with a range of 
2–10% used as significant for contractile reserve.
Table  1 displays relevant patient and study 
characteristics. There was a significant male 
predominance in all studies, 574 males (73%) with a 
relatively young patient population with mean age 
across all studies in the range of 45–62  years. All but 
one of the included studies has defined their patients’ 
resting LV EF in their inclusion criteria. In 5 studies, all 
patients have severe LV systolic dysfunction with an 
LV EF of <35%, a total of 489 patients. Three studies 
include patients with LV EF <40%, 226 patients. One 
study includes a range of LV systolic impairment from 
20 to 50%, 71 patients.
The presence of contractile reserve was associated with 
significantly lower mortality (Fig. 2), OR of 0.20 (CI 0.11, 
0.39) (P = <0.0001). The presence of contractile reserve 
was also associated with significantly lower combined 
cardiovascular events (mortality and hospitalisation with 
HF) (Fig. 3), OR 0.13 (CI 0.04, 0.40) (P = 0.0004).
Comparing studies using imaging modalities of 
radionuclide angiography (Fig. 4; 2 studies, 165 patients) 
and echocardiography (Fig. 5; 7 studies, 796 patients) for 
LV function assessment, results demonstrate that either 
modality shows similar combined outcomes: OR of 0.10 
(CI 0.03, 0.30) (P < 0.0001) for radionuclide angiography 
and an OR of 0.21 (CI 0.12, 0.38) (P < 0.00001) for 
echocardiography.
Figure 2
Forest plot of primary outcome data (cardiac mortality).
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Comparing studies using stressors of dobutamine 
(6 studies, 436 patients), dipyridamole (2 studies, 248 
patients) and exercise (1 study, 71 patients) shows 
similar combined outcomes: OR of 0.14 (CI 0.07, 0.29 
(P < 0.00001) for dobutamine, OR of 0.31 (CI 0.13, 0.72) 
(P < 0.007) for dipyridamole and OR of 0.14 (CI 0.04, 0.53) 
(P = 0.004) for exercise.
Discussion
This study confirms that in patients with non-ischaemic 
cardiomyopathy and significantly reduced EF, the presence 
of contractile reserve regardless of stressor (dobutamine/
dipyridamole/exercise), or whether measured by 
echocardiography or nuclear methods, is associated with 
mortality that is 80% lower and similarly lowers event 
and hospitalisation rates.
There has long been a description of a significant 
incremental benefit in the use of contractile reserve 
during prognostic assessment of this patient group; 
however, limitations to the data set and particularly the 
heterogeneity of methods have precluded its routine 
incorporation into clinical practice. Incremental 
prognostic benefit of the presence of CR has been 
demonstrated compared to cardiopulmonary exercise 
testing (CPET) (23). CR assessment is of particular value 
when patients have limited ambulation or have equivocal 
CPET results.
This effect may not simply be confined to the LV; 
data (excluded from this meta-analysis) by Matsumoto 
and coworkers (16) have suggested that both LV and 
RV contractile reserves are independent parameters 
associated with cardiovascular events and produced an 
incremental prognostic value compared with clinical and 
baseline echocardiographic parameters. In a combined 
model, predictions based on clinical and baseline 
echocardiographic parameters were improved by the 
addition of LV contractile reserve parameters (change in 
global strain and EF) and further improved by adding RV 
contractile reserve (RV-free wall).
A subanalysis comparing the characteristics of resting 
vs stress LV systolic function is not possible with currently 
available data; as such, we cannot make a statistical 
assessment of the incremental value of contractile reserve. 
Current predictive models based around EF are recognised 
to be limited, so an incremental improvement can be 
safely assumed. This is also backed up by two studies (22, 
23) that patients with the presence of contractile reserve 
are those with lower NYHA class and higher resting LV 
Figure 3
Forest plot of secondary outcome data (combined cardiovascular events).
Figure 4
Studies using radionuclide angiography (combined primary and secondary outcomes).
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EF with a suggestion of significant incremental value in 
prognostic assessment with positive contractile reserve.
In the Pratali 2005 study, 71 patients (61%) were 
considered as responders (change in WMSI > 0.15) and 
45 (39%) were classified as non-responders (change in 
WMSI < 0.15). Responders showed lower NYHA class 
(P = 0.03) and less severe left ventricular dysfunction 
(P = 0.02). LV EF 28.6 +/− 6.6 and NYHA 2.35 +/− 0.6 in 
responders vs LV EF 25.6 +/− 6.8 and NYHA 2.62 +/− 
0.7 in non-responders. In the Pinamonti 2002 study, 22 
(43%) patients were considered responders and 29 (57%) 
non-responders (change in LV EF >10% and peak LV EF 
40%). Those with contractile reserve also had significantly 
higher resting LV EF (P = 0.046) and lower NYHA class 
(P = 0.0028). Although these are statistically significant 
differences, the absolute numbers of LV EF are all within 
the severe category <35% and the differences in LV EF 
% are small, given observer variability and accuracy of 
imaging modalities.
Deformation imaging is becoming increasingly 
important particularly to describe the long-axis function 
of the heart. Tissue Doppler Imaging and strain are 
both powerful additive tools in the echocardiographic 
assessment of LV systolic function. The use of these 
parameters in the assessment of contractile reserve may 
allow greater reproducibility and accuracy, adding to the 
prognostic usefulness of this test (17). We have previously 
described a strong positive prognostic effect of contractile 
reserve measured by S’ from spectral Tissue Doppler 
Imaging with exercise stress in patients with systolic 
HF (18).
A recent study (19) has compared the change in the 
systolic strain rate assessed by echocardiography and 
the change in maximum first derivative of LV pressure 
(LV dP/dtmax) derived from simultaneous left heart 
catheterisation as indices of contractility under stress with 
dobutamine. They also found a significant correlation 
between the percentage change in systolic strain rate and 
the percentage change in LV dP/dtmax. This study was 
performed in both normal controls and patients with DCM 
with results indicating a clear role for echocardiographic 
measurement of strain as a valid method for contractile 
reserve assessment.
Study limitations and areas for further research
The obvious and wide heterogeneity of the individual 
study methodologies represents the major limitation 
of this study. These studies do not have standardised 
inclusion criteria and, although broadly similar, do 
not share precise definitions for DCM. There is also 
significant heterogeneity in the follow-up of each study 
which will undoubtedly impact the total event rates 
over time with fewer events occurring in studies with 
shorter periods of follow-up. Likewise, the definitions 
of contractile reserve were fixed by the individual 
study investigators. The methodologies used to define a 
significant cutoff for the presence of CR are varied and 
often not clearly described. There is an acknowledgement 
of the continuous nature of this parameter and the need 
to avoid observer variability.
Nine studies use change in WMSI as their assessment 
of contractile reserve. This has been shown to be feasible 
and reproducible in several prior studies. Of these 6 
studies, 3 use CR definition of change in WMSI > 0.25, 
the other 3 studies use different values (0.15–0.44). Other 
studies use change in LV EF as a marker of contractile 
reserve with differing values from 2% to 10%.
Figure 5
Studies using echocardiography (combined primary and secondary outcomes).
This work is licensed under a Creative Commons 
Attribution-NonCommercial 4.0 International 
License.
www.echorespract.com © 2018 The authors
 Published by Bioscientifica Ltdhttps://doi.org/10.1530/ERP-17-0054
P H Waddingham et al. Contractile reserve as a 
prognostic indicator
85:1
The majority of studies use stress echocardiography 
as their imaging modality of choices for assessment 
of CR. The stress agents used vary with dobutamine, 
dipyridamole and exercise being used; Rigo and c use both 
pharmacological stress agents as a form of comparison 
and conclude that there is clinical equivalence in 
ischaemia detection. It is less easy to understand how 
vasodilators induce a useful haemodynamic stress; 
however, there was no difference in effect size. There 
is however considerable heterogeneity in the data 
with regard to stressor dose used. Dose response to 
stressors could not be determined. The heterogeneity 
of follow-up data and small cohort sizes do not allow 
‘time to event’ prognostication; however, absence 
of CR is demonstrated to be a marker of increased 
cardiovascular risk.
Conclusions
Patients with non-ischaemic systolic HF and absent 
contractile reserve die sooner than those with confirmed 
contractile reserve. The presence of contractile reserve is 
associated with statistically significant lower mortality, 
OR 0.2 (CI 0.11, 0.39) (P < 0.00001). It does not matter 
how the patients are assessed (echocardiography or 
nuclear radionuclide imaging) nor by which agent or 
method they are stressed. Impaired contractile reserve 
also demonstrates increased risk for a range of secondary 
endpoints, particularly hospitalisation which is critical in 
planning care needs.
The heterogeneity in these studies, which vary 
widely, suggests the need to develop agreed international 
standards for assessment of contractile reserve, which 
could be used in a suitably powered prospective study 
designed to develop a better prognostic model than 
that currently offered by resting data collection. It is 
intuitively clear that documenting the heart’s ability to 
augment its function in relation to demand will offer 
more information than that acquired in the resting 
state. This study confirms this and demonstrates that 
augmentation powerfully predicts prognosis and 
cardiac events in patients with DCM and non-ischaemic 
systolic HF.
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